Early and specific antibody response to OspA in Lyme Disease.
Steven E. Schutzer(Rutgers, The State University of New Jersey), Michael Brunner, Patricia K. Coyle(St. Michael's Hospital), Benjamin J. Luft(Stony Brook School), J J Dunn(Brookhaven National Laboratory)
Cited by 63
Related Papers
Randomized, comparative study of interferon β-1a treatment regimens in MS
|Neurology|2002|633
Comparison of subcutaneous interferon beta-1a with glatiramer acetate in patients with relapsing multiple sclerosis (the REbif vs Glatiramer Acetate in Relapsing MS Disease [REGARD] study): a multicentre, randomised, parallel, open-label trial
|The Lancet Neurology|2008|484
Standardized MR imaging protocol for multiple sclerosis: Consortium of MS Centers consensus guidelines.
|PubMed|2006|287
Establishing the Proteome of Normal Human Cerebrospinal Fluid
|PLoS ONE|2010|237